Enzo Biochem, Inc.: $100m revs in F18. Pioneer in molecular diagnostics (Dx), leading convergence of clinical laboratories, life sciences and IP through devt of unique Dx platform technologies providing numerous advantages over previous standards.
Healthcare/Medical Diagnostics & Research
Based in...
US - Middle Atlantic
Clinical Stage
Disease Space
Biotechnology, Diagnostics
Public, USA
Market Cap
100MM - 500MM
527 Madison Avenue
New York, NY NY 10022
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Enzo Biochem, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Harbert Fund Advisors, Inc. 11.82 5,620,681 16.97 13F 2020-03-31
Evermore Global Advisors LLC 8.43 4,007,851 12.10 13F 2020-03-31
Renaissance Technologies LLC 6.96 3,311,978 10.00 13F 2020-03-31
The Vanguard Group, Inc. 5.01 2,383,283 7.20 Funds 2020-05-31
Vanguard Group, Inc. (Subfiler) 4.66 2,215,256 6.69 13F 2020-03-31
Dimensional Fund Advisors LP 4.35 2,066,365 6.24 13F 2020-03-31
BlackRock Institutional Trust Co. NA 3.62 1,721,606 5.20 13F 2020-03-31
Wellington Management Co. LLP 3.55 1,689,361 5.10 13F 2020-03-31
BlackRock Fund Advisors 3.29 1,563,635 4.72 13F 2020-03-31
Ariel Investments LLC 1.83 870,079 2.63 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.